Drug: bevacizumab Quarter: 2016Q3
Total Records: 786 Number of Pages: 40
| DRUGNAME | PT | EventCount |
|---|---|---|
| Bevacizumab | Hepatic steatosis | 1 |
| Bevacizumab | Hepatitis | 1 |
| Bevacizumab | Hepatitis acute | 1 |
| Bevacizumab | Hepatitis B | 1 |
| Bevacizumab | Hepatitis toxic | 1 |
| Bevacizumab | Hernia | 1 |
| BEVACIZUMAB | Hyperkeratosis | 1 |
| Bevacizumab | Hyperlipidaemia | 1 |
| Bevacizumab | Hyphaema | 1 |
| Bevacizumab | Hypotonia | 1 |
| Bevacizumab | Hypovolaemia | 1 |
| Bevacizumab | Hypovolaemic shock | 1 |
| BEVACIZUMAB | Idiosyncratic drug reaction | 1 |
| Bevacizumab | Implant site dehiscence | 1 |
| BEVACIZUMAB | Incision site abscess | 1 |
| Bevacizumab | Incorrect drug administration rate | 1 |
| Bevacizumab | Infective myositis | 1 |
| Bevacizumab | Infestation | 1 |
| BEVACIZUMAB | Inflammation | 1 |
| BEVACIZUMAB | Injection site nodule | 1 |
Total Records: 786 Number of Pages: 40